Rules in Progress

Department of Health Rules Page

Recent rules and law changes

Pharmacy related email inbox: PharmacyRules@doh.wa.gov

Significant legislative rule-making process

CR-101 – Statement of Inquiry (Rules under development/examination – stakeholder workshops)

CR-102 – Notice of Proposed Rule Making (Approved rule language, official public comment period and notice of rules hearing.)

CR-103 – Rule making Order (Notice of adopted rules or notice of emergency rule adoption)

CR-105 – Expedited Rule Making due to the limited scope of a CR-105, there is no public hearing. A person may object to the use of the expedited rulemaking process within 45 days after the notice of proposed rulemaking is filed.

Inquiry Phase (CR-101)

Medication Assistance

WSR 22-02-015 (PDF)

Suspicious Orders and Zero Reports

WSR 23-10-012 (PDF)

Mobile Opioid Treatment Program Units 

WSR 23-18-046 (PDF)

Transfer Practices (Brown and White Bagging)

WSR 23-20-115 (PDF)

Uniform Facility Enforcement Framework

WSR 24-15-057 (PDF)

Permanent Facility Closure Requirements

WSR 24-13-061 (PDF)

Considering Scheduling Kratom

WSR 24-18-005 (PDF)

Utilization of Pharmacy Ancillary Personnel

WSR 24-18-032 (PDF)

Rule Proposed - Pending public rules hearing (CR-102)

Dialysate and Dialysis Device Manufacturers and Wholesalers

WSR 24-24-028 (PDF)

WSR 24-14-140 (PDF)

Supplemental CR-102 - Dialysis WSR 24-24-028 (Filed Nov 22 2024) 

WSR 24-14-140 (PDF)

Drugs Stored Outside of the Pharmacy 

WSR 24-17-006 (PDF)

Accessible Labeling Standards

WSR 24-17-046 (PDF)

Expedited Rule – (CR-105)

Incorporations by Reference in chapter 246-945 WAC

WSR 24-11-152 (PDF)

Recently Adopted Rules (CR-103)

Chapter 246-945 WAC Technical Updates

WSR 24-11-060 (PDF)

USP <795> and <797> Incorporation

WSR 24-09-051 (PDF)

Title 21 C.F.R. Incorporation in WA 246-945-040

WSR 24-01-102 (PDF)

Medication Assistance Emergency Rules

WSR 24-14-078 (PDF)

Naloxone as OTC Emergency Rules

WSR 24-16-085 (PDF)

Wildlife Capture Drug Classification

WSR 24-15-075 (PDF)

Removing Fenfluramine from Schedule IV Substance List

WSR 24-15-076 (PDF)

Prescription Transfer Requirement

WSR 24-24-024 (PDF)

Pharmacy Intern Registration

WSR 24-07-007 (PDF)

Contact and connect

To get important information about the pharmacy commission, subscribe for updates at the bottom of the page.